Fundz

Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital

PRIVATEJul 09, 2020

Amount Raised

$22 Million

Round Type

Series A

MissoulaBiotechnologyHealth CareTherapeutics

Description

Inimmune, www.inimmune.com, a biotechnology company developing immune therapies and components for more effective vaccines, announced today that it raised $22 million in Series A funding. It was the Missoula-based company's first outside investment. The round was led by Two Bear Capital, www.twobearcapital.com, a new firm based in Whitefish, Montana. Two Bear Capital Founder and Managing Partner Michael Goguen will join Inimmune's board of directors.

Quick answer

Inimmune Corporation raised $22 Million in a Series A round, dated July 9, 2020. Inimmune Corporation is based in Missoula, Montana, United States.

How much did Inimmune Corporation raise?
Inimmune Corporation raised $22 Million in a Series A round on July 9, 2020.
What does Inimmune Corporation do?
Inimmune is a clinical-stage biotechnology company focused on the discovery and development of next-generation immunotherapies for the treatment of infectious diseases, allergy, and cancer.
Where is Inimmune Corporation based and how big is it?
Inimmune Corporation is based in Missoula, Montana, United States.
Who are the decision-makers at Inimmune Corporation?
Fundz holds 1 contact at Inimmune Corporation. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Inimmune Corporation that raised within 45 days of this round, from Fundz verified event records.

  • Cartesian Therapeutics, Inc. raised $25M on August 18, 2020.
  • Jade Biosciences raised $76M on August 14, 2020.
  • Dyne Therapeutics raised $116M on August 14, 2020.
  • Vaccinex raised $8M on August 11, 2020.
  • Korsana Biosciences raised $24M on August 11, 2020.
  • Biohaven raised $450M (Funding Round) on August 7, 2020.

Who to call at Inimmune Corporation, and when

A new round usually means Inimmune Corporation is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Inimmune Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Inimmune Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Inimmune Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Inimmune Corporation

Location

Missoula, Montana, United States

About

Inimmune is a clinical-stage biotechnology company focused on the discovery and development of next-generation immunotherapies for the treatment of infectious diseases, allergy, and cancer. Leveraging its proprietary technology platforms, Inimmune is dedicated to creating safe and effective treatments that harness the immune system to improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Inimmune Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Inimmune Corporation's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Inimmune Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.